Wedbush Starts Endologix (ELGX) at Outperform; Promising Endovascular Pure Play
Tweet Send to a Friend
Wedbush initiates coverage on Endologix (NASDAQ: ELGX) with a Outperform. PT $9.
Wedbush analyst says, "We believe Endologix is poised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "We believe Endologix is poised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
